復星醫藥(02196.HK)擬轉讓上海復健55%股權
格隆匯4月11日丨復星醫藥(02196.HK)公告,於2025年4月11日,公司與復星高科技、李凡以及關曉暉訂立股權轉讓協議,據此,公司同意出售、且復星高科技、李凡以及關曉暉同意分別以現金對價人民幣13,993,682元、人民幣12,497,806元、人民幣48,254元購買上海復健29.00%、25.90%、0.10%的股權。本次轉讓完成後,公司持有上海復健的股權比例將由本次轉讓前的100%降至45%。
上海復健成立於2019年9月,註冊地爲上海市,法定代表人爲關曉暉。上海復健的經營範圍包括股權投資管理,投資管理,投資諮詢。
本次轉讓爲根據中國證券投資基金業協會等相關最新規定而對標的公司股權結構所作調整。本次轉讓完成後,公司持有上海復健的股權比例將由本次轉讓前的100%降至45%,上海復健及其持有份額的南京復鑫、星盛復盈、深圳復鑫將由公司的附屬公司轉爲聯合營公司。預計本次轉讓對集團無損益影響。本次轉讓所獲款項將用於集團運營資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.